An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
Clinical trial NCT00455429 · TERMINATED
Trial details
- NCT number
- NCT00455429
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-03-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.